SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, Jung S, Camilleri-Broet S, Gonzalez AV, Guiot MC, Lockwood WW, Spicer JD, Agaimy A, Pastor WA, Dostie J, Rak J, Foulkes WD, Huang S.
Xue Y, et al. Among authors: spicer jd.
Nat Commun. 2019 Feb 4;10(1):557. doi: 10.1038/s41467-019-08380-1.
Nat Commun. 2019.
PMID: 30718506
Free PMC article.